nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiotropium—CYP3A4—Calcitriol—osteoporosis	0.0701	0.158	CbGbCtD
Tiotropium—CYP3A4—Estropipate—osteoporosis	0.0701	0.158	CbGbCtD
Tiotropium—CYP2D6—Cholecalciferol—osteoporosis	0.0568	0.128	CbGbCtD
Tiotropium—CYP3A4—Ergocalciferol—osteoporosis	0.056	0.126	CbGbCtD
Tiotropium—CYP3A4—Raloxifene—osteoporosis	0.0467	0.105	CbGbCtD
Tiotropium—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0451	0.102	CbGbCtD
Tiotropium—CYP3A4—Cholecalciferol—osteoporosis	0.0361	0.0814	CbGbCtD
Tiotropium—CYP3A4—Conjugated Estrogens—osteoporosis	0.0331	0.0748	CbGbCtD
Tiotropium—CYP3A4—Estradiol—osteoporosis	0.0291	0.0656	CbGbCtD
Tiotropium—Arthralgia—Risedronate—osteoporosis	0.000754	0.00136	CcSEcCtD
Tiotropium—Myalgia—Risedronate—osteoporosis	0.000754	0.00136	CcSEcCtD
Tiotropium—Constipation—Ibandronate—osteoporosis	0.00075	0.00135	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000749	0.00135	CcSEcCtD
Tiotropium—Pruritus—Etidronic acid—osteoporosis	0.000748	0.00135	CcSEcCtD
Tiotropium—Gastrointestinal pain—Estropipate—osteoporosis	0.000748	0.00135	CcSEcCtD
Tiotropium—Mental disorder—Conjugated Estrogens—osteoporosis	0.000745	0.00134	CcSEcCtD
Tiotropium—Back pain—Zoledronate—osteoporosis	0.000744	0.00134	CcSEcCtD
Tiotropium—Oedema—Ethinyl Estradiol—osteoporosis	0.000741	0.00133	CcSEcCtD
Tiotropium—Malnutrition—Conjugated Estrogens—osteoporosis	0.00074	0.00133	CcSEcCtD
Tiotropium—Loss of consciousness—Pamidronate—osteoporosis	0.00074	0.00133	CcSEcCtD
Tiotropium—Dry mouth—Risedronate—osteoporosis	0.000737	0.00133	CcSEcCtD
Tiotropium—Urinary tract infection—Estradiol—osteoporosis	0.000737	0.00133	CcSEcCtD
Tiotropium—Gastrointestinal pain—Alendronate—osteoporosis	0.000737	0.00133	CcSEcCtD
Tiotropium—Infection—Ethinyl Estradiol—osteoporosis	0.000736	0.00132	CcSEcCtD
Tiotropium—Cough—Pamidronate—osteoporosis	0.000735	0.00132	CcSEcCtD
Tiotropium—Constipation—Calcitriol—osteoporosis	0.000734	0.00132	CcSEcCtD
Tiotropium—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000727	0.00131	CcSEcCtD
Tiotropium—Hypertension—Pamidronate—osteoporosis	0.000727	0.00131	CcSEcCtD
Tiotropium—Urticaria—Estropipate—osteoporosis	0.000727	0.00131	CcSEcCtD
Tiotropium—Vision blurred—Zoledronate—osteoporosis	0.000725	0.0013	CcSEcCtD
Tiotropium—Gastrointestinal pain—Raloxifene—osteoporosis	0.000724	0.0013	CcSEcCtD
Tiotropium—Abdominal pain—Estropipate—osteoporosis	0.000723	0.0013	CcSEcCtD
Tiotropium—Skin disorder—Ethinyl Estradiol—osteoporosis	0.00072	0.0013	CcSEcCtD
Tiotropium—Infection—Risedronate—osteoporosis	0.000718	0.00129	CcSEcCtD
Tiotropium—Gastrointestinal pain—Ibandronate—osteoporosis	0.000717	0.00129	CcSEcCtD
Tiotropium—Myalgia—Pamidronate—osteoporosis	0.000717	0.00129	CcSEcCtD
Tiotropium—Arthralgia—Pamidronate—osteoporosis	0.000717	0.00129	CcSEcCtD
Tiotropium—Back pain—Conjugated Estrogens—osteoporosis	0.000716	0.00129	CcSEcCtD
Tiotropium—Urticaria—Alendronate—osteoporosis	0.000716	0.00129	CcSEcCtD
Tiotropium—Epistaxis—Estradiol—osteoporosis	0.000715	0.00129	CcSEcCtD
Tiotropium—Abdominal pain—Alendronate—osteoporosis	0.000712	0.00128	CcSEcCtD
Tiotropium—Sinusitis—Estradiol—osteoporosis	0.000711	0.00128	CcSEcCtD
Tiotropium—Shock—Risedronate—osteoporosis	0.000711	0.00128	CcSEcCtD
Tiotropium—Nervous system disorder—Risedronate—osteoporosis	0.000709	0.00128	CcSEcCtD
Tiotropium—Angioedema—Zoledronate—osteoporosis	0.000703	0.00126	CcSEcCtD
Tiotropium—Skin disorder—Risedronate—osteoporosis	0.000702	0.00126	CcSEcCtD
Tiotropium—Gastrointestinal pain—Calcitriol—osteoporosis	0.000702	0.00126	CcSEcCtD
Tiotropium—Abdominal pain—Raloxifene—osteoporosis	0.0007	0.00126	CcSEcCtD
Tiotropium—Vision blurred—Conjugated Estrogens—osteoporosis	0.000698	0.00126	CcSEcCtD
Tiotropium—Urticaria—Ibandronate—osteoporosis	0.000697	0.00125	CcSEcCtD
Tiotropium—Abdominal pain—Ibandronate—osteoporosis	0.000693	0.00125	CcSEcCtD
Tiotropium—Syncope—Zoledronate—osteoporosis	0.00069	0.00124	CcSEcCtD
Tiotropium—Oedema—Pamidronate—osteoporosis	0.000687	0.00124	CcSEcCtD
Tiotropium—Infection—Pamidronate—osteoporosis	0.000683	0.00123	CcSEcCtD
Tiotropium—Rhinitis—Estradiol—osteoporosis	0.000682	0.00123	CcSEcCtD
Tiotropium—Urticaria—Calcitriol—osteoporosis	0.000682	0.00123	CcSEcCtD
Tiotropium—Palpitations—Zoledronate—osteoporosis	0.00068	0.00122	CcSEcCtD
Tiotropium—Abdominal pain—Calcitriol—osteoporosis	0.000679	0.00122	CcSEcCtD
Tiotropium—Angioedema—Conjugated Estrogens—osteoporosis	0.000677	0.00122	CcSEcCtD
Tiotropium—Shock—Pamidronate—osteoporosis	0.000676	0.00122	CcSEcCtD
Tiotropium—Loss of consciousness—Zoledronate—osteoporosis	0.000676	0.00122	CcSEcCtD
Tiotropium—Pharyngitis—Estradiol—osteoporosis	0.000676	0.00122	CcSEcCtD
Tiotropium—Hypersensitivity—Estropipate—osteoporosis	0.000674	0.00121	CcSEcCtD
Tiotropium—Nervous system disorder—Pamidronate—osteoporosis	0.000674	0.00121	CcSEcCtD
Tiotropium—Urinary tract disorder—Estradiol—osteoporosis	0.000672	0.00121	CcSEcCtD
Tiotropium—Vomiting—Etidronic acid—osteoporosis	0.000672	0.00121	CcSEcCtD
Tiotropium—Cough—Zoledronate—osteoporosis	0.000671	0.00121	CcSEcCtD
Tiotropium—Oedema peripheral—Estradiol—osteoporosis	0.000671	0.00121	CcSEcCtD
Tiotropium—Tachycardia—Pamidronate—osteoporosis	0.000671	0.00121	CcSEcCtD
Tiotropium—Connective tissue disorder—Estradiol—osteoporosis	0.000669	0.0012	CcSEcCtD
Tiotropium—Urethral disorder—Estradiol—osteoporosis	0.000667	0.0012	CcSEcCtD
Tiotropium—Rash—Etidronic acid—osteoporosis	0.000667	0.0012	CcSEcCtD
Tiotropium—Dermatitis—Etidronic acid—osteoporosis	0.000666	0.0012	CcSEcCtD
Tiotropium—Syncope—Conjugated Estrogens—osteoporosis	0.000664	0.00119	CcSEcCtD
Tiotropium—Hypertension—Zoledronate—osteoporosis	0.000664	0.00119	CcSEcCtD
Tiotropium—Hypersensitivity—Alendronate—osteoporosis	0.000664	0.00119	CcSEcCtD
Tiotropium—Headache—Etidronic acid—osteoporosis	0.000662	0.00119	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000659	0.00118	CcSEcCtD
Tiotropium—Visual impairment—Estradiol—osteoporosis	0.000656	0.00118	CcSEcCtD
Tiotropium—Chest pain—Zoledronate—osteoporosis	0.000655	0.00118	CcSEcCtD
Tiotropium—Myalgia—Zoledronate—osteoporosis	0.000655	0.00118	CcSEcCtD
Tiotropium—Arthralgia—Zoledronate—osteoporosis	0.000655	0.00118	CcSEcCtD
Tiotropium—Palpitations—Conjugated Estrogens—osteoporosis	0.000654	0.00118	CcSEcCtD
Tiotropium—Insomnia—Risedronate—osteoporosis	0.000654	0.00118	CcSEcCtD
Tiotropium—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000651	0.00117	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.00065	0.00117	CcSEcCtD
Tiotropium—Paraesthesia—Risedronate—osteoporosis	0.000649	0.00117	CcSEcCtD
Tiotropium—Pruritus—Estropipate—osteoporosis	0.000647	0.00116	CcSEcCtD
Tiotropium—Hypersensitivity—Ibandronate—osteoporosis	0.000646	0.00116	CcSEcCtD
Tiotropium—Cough—Conjugated Estrogens—osteoporosis	0.000646	0.00116	CcSEcCtD
Tiotropium—Dry mouth—Zoledronate—osteoporosis	0.00064	0.00115	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00064	0.00115	CcSEcCtD
Tiotropium—Pruritus—Alendronate—osteoporosis	0.000637	0.00115	CcSEcCtD
Tiotropium—Dyspepsia—Risedronate—osteoporosis	0.000636	0.00114	CcSEcCtD
Tiotropium—Eye disorder—Estradiol—osteoporosis	0.000636	0.00114	CcSEcCtD
Tiotropium—Constipation—Ethinyl Estradiol—osteoporosis	0.000634	0.00114	CcSEcCtD
Tiotropium—Hypersensitivity—Calcitriol—osteoporosis	0.000633	0.00114	CcSEcCtD
Tiotropium—Arthralgia—Conjugated Estrogens—osteoporosis	0.00063	0.00113	CcSEcCtD
Tiotropium—Myalgia—Conjugated Estrogens—osteoporosis	0.00063	0.00113	CcSEcCtD
Tiotropium—Chest pain—Conjugated Estrogens—osteoporosis	0.00063	0.00113	CcSEcCtD
Tiotropium—Nausea—Etidronic acid—osteoporosis	0.000628	0.00113	CcSEcCtD
Tiotropium—Oedema—Zoledronate—osteoporosis	0.000628	0.00113	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000626	0.00113	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000626	0.00113	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Risedronate—osteoporosis	0.000624	0.00112	CcSEcCtD
Tiotropium—Infection—Zoledronate—osteoporosis	0.000624	0.00112	CcSEcCtD
Tiotropium—Insomnia—Pamidronate—osteoporosis	0.000621	0.00112	CcSEcCtD
Tiotropium—Pruritus—Ibandronate—osteoporosis	0.000621	0.00112	CcSEcCtD
Tiotropium—Constipation—Risedronate—osteoporosis	0.000618	0.00111	CcSEcCtD
Tiotropium—Angiopathy—Estradiol—osteoporosis	0.000618	0.00111	CcSEcCtD
Tiotropium—Shock—Zoledronate—osteoporosis	0.000617	0.00111	CcSEcCtD
Tiotropium—Paraesthesia—Pamidronate—osteoporosis	0.000617	0.00111	CcSEcCtD
Tiotropium—Nervous system disorder—Zoledronate—osteoporosis	0.000615	0.00111	CcSEcCtD
Tiotropium—Immune system disorder—Estradiol—osteoporosis	0.000615	0.00111	CcSEcCtD
Tiotropium—Mediastinal disorder—Estradiol—osteoporosis	0.000614	0.0011	CcSEcCtD
Tiotropium—Tachycardia—Zoledronate—osteoporosis	0.000613	0.0011	CcSEcCtD
Tiotropium—Skin disorder—Zoledronate—osteoporosis	0.00061	0.0011	CcSEcCtD
Tiotropium—Pruritus—Calcitriol—osteoporosis	0.000607	0.00109	CcSEcCtD
Tiotropium—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000606	0.00109	CcSEcCtD
Tiotropium—Dyspepsia—Pamidronate—osteoporosis	0.000605	0.00109	CcSEcCtD
Tiotropium—Dizziness—Estropipate—osteoporosis	0.000605	0.00109	CcSEcCtD
Tiotropium—Oedema—Conjugated Estrogens—osteoporosis	0.000604	0.00109	CcSEcCtD
Tiotropium—Infection—Conjugated Estrogens—osteoporosis	0.0006	0.00108	CcSEcCtD
Tiotropium—Mental disorder—Estradiol—osteoporosis	0.000596	0.00107	CcSEcCtD
Tiotropium—Dizziness—Alendronate—osteoporosis	0.000596	0.00107	CcSEcCtD
Tiotropium—Shock—Conjugated Estrogens—osteoporosis	0.000595	0.00107	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000593	0.00107	CcSEcCtD
Tiotropium—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000593	0.00107	CcSEcCtD
Tiotropium—Malnutrition—Estradiol—osteoporosis	0.000593	0.00107	CcSEcCtD
Tiotropium—Gastrointestinal pain—Risedronate—osteoporosis	0.000591	0.00106	CcSEcCtD
Tiotropium—Tachycardia—Conjugated Estrogens—osteoporosis	0.00059	0.00106	CcSEcCtD
Tiotropium—Urticaria—Ethinyl Estradiol—osteoporosis	0.000589	0.00106	CcSEcCtD
Tiotropium—Constipation—Pamidronate—osteoporosis	0.000588	0.00106	CcSEcCtD
Tiotropium—Skin disorder—Conjugated Estrogens—osteoporosis	0.000587	0.00106	CcSEcCtD
Tiotropium—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000586	0.00105	CcSEcCtD
Tiotropium—Dizziness—Raloxifene—osteoporosis	0.000586	0.00105	CcSEcCtD
Tiotropium—Vomiting—Estropipate—osteoporosis	0.000582	0.00105	CcSEcCtD
Tiotropium—Dizziness—Ibandronate—osteoporosis	0.00058	0.00104	CcSEcCtD
Tiotropium—Rash—Estropipate—osteoporosis	0.000577	0.00104	CcSEcCtD
Tiotropium—Dermatitis—Estropipate—osteoporosis	0.000576	0.00104	CcSEcCtD
Tiotropium—Urticaria—Risedronate—osteoporosis	0.000574	0.00103	CcSEcCtD
Tiotropium—Back pain—Estradiol—osteoporosis	0.000573	0.00103	CcSEcCtD
Tiotropium—Headache—Estropipate—osteoporosis	0.000573	0.00103	CcSEcCtD
Tiotropium—Vomiting—Alendronate—osteoporosis	0.000573	0.00103	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000572	0.00103	CcSEcCtD
Tiotropium—Abdominal pain—Risedronate—osteoporosis	0.000571	0.00103	CcSEcCtD
Tiotropium—Rash—Alendronate—osteoporosis	0.000568	0.00102	CcSEcCtD
Tiotropium—Insomnia—Zoledronate—osteoporosis	0.000568	0.00102	CcSEcCtD
Tiotropium—Dermatitis—Alendronate—osteoporosis	0.000567	0.00102	CcSEcCtD
Tiotropium—Headache—Alendronate—osteoporosis	0.000564	0.00102	CcSEcCtD
Tiotropium—Paraesthesia—Zoledronate—osteoporosis	0.000564	0.00101	CcSEcCtD
Tiotropium—Vomiting—Raloxifene—osteoporosis	0.000563	0.00101	CcSEcCtD
Tiotropium—Gastrointestinal pain—Pamidronate—osteoporosis	0.000562	0.00101	CcSEcCtD
Tiotropium—Rash—Raloxifene—osteoporosis	0.000559	0.001	CcSEcCtD
Tiotropium—Dermatitis—Raloxifene—osteoporosis	0.000558	0.001	CcSEcCtD
Tiotropium—Vomiting—Ibandronate—osteoporosis	0.000558	0.001	CcSEcCtD
Tiotropium—Headache—Raloxifene—osteoporosis	0.000555	0.000998	CcSEcCtD
Tiotropium—Rash—Ibandronate—osteoporosis	0.000553	0.000995	CcSEcCtD
Tiotropium—Dermatitis—Ibandronate—osteoporosis	0.000552	0.000994	CcSEcCtD
Tiotropium—Dyspepsia—Zoledronate—osteoporosis	0.000552	0.000994	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000551	0.000991	CcSEcCtD
Tiotropium—Headache—Ibandronate—osteoporosis	0.000549	0.000988	CcSEcCtD
Tiotropium—Insomnia—Conjugated Estrogens—osteoporosis	0.000547	0.000983	CcSEcCtD
Tiotropium—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000546	0.000983	CcSEcCtD
Tiotropium—Vomiting—Calcitriol—osteoporosis	0.000546	0.000982	CcSEcCtD
Tiotropium—Nausea—Estropipate—osteoporosis	0.000543	0.000977	CcSEcCtD
Tiotropium—Abdominal pain—Pamidronate—osteoporosis	0.000543	0.000977	CcSEcCtD
Tiotropium—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000543	0.000976	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000542	0.000975	CcSEcCtD
Tiotropium—Angioedema—Estradiol—osteoporosis	0.000542	0.000974	CcSEcCtD
Tiotropium—Rash—Calcitriol—osteoporosis	0.000541	0.000974	CcSEcCtD
Tiotropium—Dermatitis—Calcitriol—osteoporosis	0.000541	0.000973	CcSEcCtD
Tiotropium—Headache—Calcitriol—osteoporosis	0.000538	0.000968	CcSEcCtD
Tiotropium—Constipation—Zoledronate—osteoporosis	0.000537	0.000966	CcSEcCtD
Tiotropium—Nausea—Alendronate—osteoporosis	0.000535	0.000963	CcSEcCtD
Tiotropium—Hypersensitivity—Risedronate—osteoporosis	0.000533	0.000958	CcSEcCtD
Tiotropium—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000532	0.000957	CcSEcCtD
Tiotropium—Syncope—Estradiol—osteoporosis	0.000531	0.000956	CcSEcCtD
Tiotropium—Nausea—Raloxifene—osteoporosis	0.000526	0.000947	CcSEcCtD
Tiotropium—Pruritus—Ethinyl Estradiol—osteoporosis	0.000524	0.000944	CcSEcCtD
Tiotropium—Palpitations—Estradiol—osteoporosis	0.000524	0.000942	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000522	0.000939	CcSEcCtD
Tiotropium—Nausea—Ibandronate—osteoporosis	0.000521	0.000937	CcSEcCtD
Tiotropium—Loss of consciousness—Estradiol—osteoporosis	0.000521	0.000937	CcSEcCtD
Tiotropium—Cough—Estradiol—osteoporosis	0.000517	0.00093	CcSEcCtD
Tiotropium—Constipation—Conjugated Estrogens—osteoporosis	0.000517	0.00093	CcSEcCtD
Tiotropium—Gastrointestinal pain—Zoledronate—osteoporosis	0.000513	0.000923	CcSEcCtD
Tiotropium—Hypertension—Estradiol—osteoporosis	0.000512	0.00092	CcSEcCtD
Tiotropium—Pruritus—Risedronate—osteoporosis	0.000511	0.00092	CcSEcCtD
Tiotropium—Nausea—Calcitriol—osteoporosis	0.00051	0.000917	CcSEcCtD
Tiotropium—Hypersensitivity—Pamidronate—osteoporosis	0.000506	0.000911	CcSEcCtD
Tiotropium—Chest pain—Estradiol—osteoporosis	0.000505	0.000908	CcSEcCtD
Tiotropium—Myalgia—Estradiol—osteoporosis	0.000505	0.000908	CcSEcCtD
Tiotropium—Arthralgia—Estradiol—osteoporosis	0.000505	0.000908	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000501	0.000901	CcSEcCtD
Tiotropium—Urticaria—Zoledronate—osteoporosis	0.000499	0.000897	CcSEcCtD
Tiotropium—Abdominal pain—Zoledronate—osteoporosis	0.000496	0.000893	CcSEcCtD
Tiotropium—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000494	0.000889	CcSEcCtD
Tiotropium—Dry mouth—Estradiol—osteoporosis	0.000493	0.000888	CcSEcCtD
Tiotropium—Dizziness—Ethinyl Estradiol—osteoporosis	0.00049	0.000882	CcSEcCtD
Tiotropium—Pruritus—Pamidronate—osteoporosis	0.000486	0.000875	CcSEcCtD
Tiotropium—Oedema—Estradiol—osteoporosis	0.000484	0.00087	CcSEcCtD
Tiotropium—Infection—Estradiol—osteoporosis	0.000481	0.000864	CcSEcCtD
Tiotropium—Urticaria—Conjugated Estrogens—osteoporosis	0.00048	0.000864	CcSEcCtD
Tiotropium—Dizziness—Risedronate—osteoporosis	0.000478	0.00086	CcSEcCtD
Tiotropium—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000478	0.000859	CcSEcCtD
Tiotropium—Shock—Estradiol—osteoporosis	0.000476	0.000856	CcSEcCtD
Tiotropium—Nervous system disorder—Estradiol—osteoporosis	0.000474	0.000853	CcSEcCtD
Tiotropium—Tachycardia—Estradiol—osteoporosis	0.000472	0.000849	CcSEcCtD
Tiotropium—Vomiting—Ethinyl Estradiol—osteoporosis	0.000471	0.000848	CcSEcCtD
Tiotropium—Skin disorder—Estradiol—osteoporosis	0.00047	0.000845	CcSEcCtD
Tiotropium—Rash—Ethinyl Estradiol—osteoporosis	0.000467	0.000841	CcSEcCtD
Tiotropium—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000467	0.00084	CcSEcCtD
Tiotropium—Headache—Ethinyl Estradiol—osteoporosis	0.000464	0.000836	CcSEcCtD
Tiotropium—Hypersensitivity—Zoledronate—osteoporosis	0.000462	0.000832	CcSEcCtD
Tiotropium—Vomiting—Risedronate—osteoporosis	0.00046	0.000827	CcSEcCtD
Tiotropium—Rash—Risedronate—osteoporosis	0.000456	0.00082	CcSEcCtD
Tiotropium—Dermatitis—Risedronate—osteoporosis	0.000455	0.000819	CcSEcCtD
Tiotropium—Dizziness—Pamidronate—osteoporosis	0.000454	0.000817	CcSEcCtD
Tiotropium—Headache—Risedronate—osteoporosis	0.000453	0.000815	CcSEcCtD
Tiotropium—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000445	0.000801	CcSEcCtD
Tiotropium—Pruritus—Zoledronate—osteoporosis	0.000444	0.000799	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000441	0.000793	CcSEcCtD
Tiotropium—Nausea—Ethinyl Estradiol—osteoporosis	0.00044	0.000792	CcSEcCtD
Tiotropium—Insomnia—Estradiol—osteoporosis	0.000437	0.000787	CcSEcCtD
Tiotropium—Vomiting—Pamidronate—osteoporosis	0.000437	0.000786	CcSEcCtD
Tiotropium—Paraesthesia—Estradiol—osteoporosis	0.000434	0.000781	CcSEcCtD
Tiotropium—Rash—Pamidronate—osteoporosis	0.000433	0.000779	CcSEcCtD
Tiotropium—Dermatitis—Pamidronate—osteoporosis	0.000433	0.000779	CcSEcCtD
Tiotropium—Headache—Pamidronate—osteoporosis	0.00043	0.000774	CcSEcCtD
Tiotropium—Nausea—Risedronate—osteoporosis	0.000429	0.000772	CcSEcCtD
Tiotropium—Pruritus—Conjugated Estrogens—osteoporosis	0.000428	0.000769	CcSEcCtD
Tiotropium—Dyspepsia—Estradiol—osteoporosis	0.000426	0.000766	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Estradiol—osteoporosis	0.000418	0.000751	CcSEcCtD
Tiotropium—Dizziness—Zoledronate—osteoporosis	0.000415	0.000747	CcSEcCtD
Tiotropium—Constipation—Estradiol—osteoporosis	0.000414	0.000744	CcSEcCtD
Tiotropium—Nausea—Pamidronate—osteoporosis	0.000408	0.000734	CcSEcCtD
Tiotropium—Dizziness—Conjugated Estrogens—osteoporosis	0.0004	0.000719	CcSEcCtD
Tiotropium—Vomiting—Zoledronate—osteoporosis	0.000399	0.000718	CcSEcCtD
Tiotropium—Rash—Zoledronate—osteoporosis	0.000396	0.000712	CcSEcCtD
Tiotropium—Gastrointestinal pain—Estradiol—osteoporosis	0.000396	0.000712	CcSEcCtD
Tiotropium—Dermatitis—Zoledronate—osteoporosis	0.000395	0.000711	CcSEcCtD
Tiotropium—Headache—Zoledronate—osteoporosis	0.000393	0.000707	CcSEcCtD
Tiotropium—Vomiting—Conjugated Estrogens—osteoporosis	0.000384	0.000691	CcSEcCtD
Tiotropium—Urticaria—Estradiol—osteoporosis	0.000384	0.000691	CcSEcCtD
Tiotropium—Abdominal pain—Estradiol—osteoporosis	0.000382	0.000688	CcSEcCtD
Tiotropium—Rash—Conjugated Estrogens—osteoporosis	0.000381	0.000686	CcSEcCtD
Tiotropium—Dermatitis—Conjugated Estrogens—osteoporosis	0.000381	0.000685	CcSEcCtD
Tiotropium—Headache—Conjugated Estrogens—osteoporosis	0.000379	0.000681	CcSEcCtD
Tiotropium—Nausea—Zoledronate—osteoporosis	0.000373	0.000671	CcSEcCtD
Tiotropium—Nausea—Conjugated Estrogens—osteoporosis	0.000359	0.000646	CcSEcCtD
Tiotropium—Hypersensitivity—Estradiol—osteoporosis	0.000356	0.000641	CcSEcCtD
Tiotropium—Pruritus—Estradiol—osteoporosis	0.000342	0.000616	CcSEcCtD
Tiotropium—Dizziness—Estradiol—osteoporosis	0.00032	0.000575	CcSEcCtD
Tiotropium—Vomiting—Estradiol—osteoporosis	0.000308	0.000553	CcSEcCtD
Tiotropium—Rash—Estradiol—osteoporosis	0.000305	0.000549	CcSEcCtD
Tiotropium—Dermatitis—Estradiol—osteoporosis	0.000305	0.000548	CcSEcCtD
Tiotropium—Headache—Estradiol—osteoporosis	0.000303	0.000545	CcSEcCtD
Tiotropium—Nausea—Estradiol—osteoporosis	0.000287	0.000517	CcSEcCtD
Tiotropium—CHRM3—GPCR downstream signaling—CNR2—osteoporosis	1.67e-06	0.00166	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—MGLL—osteoporosis	1.66e-06	0.00166	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—CNR2—osteoporosis	1.65e-06	0.00165	CbGpPWpGaD
Tiotropium—CHRM5—GPCR ligand binding—POMC—osteoporosis	1.65e-06	0.00164	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—CALCA—osteoporosis	1.62e-06	0.00161	CbGpPWpGaD
Tiotropium—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	1.6e-06	0.00159	CbGpPWpGaD
Tiotropium—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	1.57e-06	0.00157	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—TLN1—osteoporosis	1.56e-06	0.00156	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—PTH—osteoporosis	1.56e-06	0.00156	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—PTH—osteoporosis	1.56e-06	0.00155	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—PTH—osteoporosis	1.54e-06	0.00154	CbGpPWpGaD
Tiotropium—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	1.52e-06	0.00152	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—CNR2—osteoporosis	1.52e-06	0.00152	CbGpPWpGaD
Tiotropium—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	1.52e-06	0.00152	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—CNR2—osteoporosis	1.52e-06	0.00151	CbGpPWpGaD
Tiotropium—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	1.5e-06	0.0015	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—CNR2—osteoporosis	1.5e-06	0.0015	CbGpPWpGaD
Tiotropium—CYP2D6—Biological oxidations—POMC—osteoporosis	1.47e-06	0.00146	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—WNT1—osteoporosis	1.43e-06	0.00143	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—WNT1—osteoporosis	1.42e-06	0.00142	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—PTHLH—osteoporosis	1.42e-06	0.00142	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—PTHLH—osteoporosis	1.42e-06	0.00142	CbGpPWpGaD
Tiotropium—CHRM2—SIDS Susceptibility Pathways—TNF—osteoporosis	1.41e-06	0.00141	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—IDH2—osteoporosis	1.41e-06	0.00141	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—WNT1—osteoporosis	1.41e-06	0.00141	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—PTHLH—osteoporosis	1.41e-06	0.0014	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—MGLL—osteoporosis	1.39e-06	0.00139	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—MGLL—osteoporosis	1.39e-06	0.00139	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PKM—osteoporosis	1.38e-06	0.00138	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—FDPS—osteoporosis	1.38e-06	0.00138	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—MGLL—osteoporosis	1.38e-06	0.00137	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—LRP5—osteoporosis	1.36e-06	0.00136	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—LRP5—osteoporosis	1.36e-06	0.00135	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—P4HB—osteoporosis	1.35e-06	0.00134	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—LRP5—osteoporosis	1.34e-06	0.00134	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—CYP27A1—osteoporosis	1.33e-06	0.00132	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PGLS—osteoporosis	1.31e-06	0.00131	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GPD2—osteoporosis	1.31e-06	0.00131	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—PTH—osteoporosis	1.31e-06	0.00131	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—LRP6—osteoporosis	1.3e-06	0.0013	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—LRP6—osteoporosis	1.3e-06	0.00129	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—PTHLH—osteoporosis	1.29e-06	0.00129	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—ACP5—osteoporosis	1.29e-06	0.00129	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—PTHLH—osteoporosis	1.29e-06	0.00129	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—RAP1A—osteoporosis	1.29e-06	0.00128	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—LRP6—osteoporosis	1.28e-06	0.00128	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—PTHLH—osteoporosis	1.28e-06	0.00127	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CNR2—osteoporosis	1.28e-06	0.00127	CbGpPWpGaD
Tiotropium—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	1.27e-06	0.00127	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—ADCY5—osteoporosis	1.27e-06	0.00126	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—NFATC1—osteoporosis	1.25e-06	0.00125	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—CALCA—osteoporosis	1.25e-06	0.00125	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—CALCA—osteoporosis	1.25e-06	0.00125	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—DKK1—osteoporosis	1.25e-06	0.00124	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—CALCA—osteoporosis	1.24e-06	0.00123	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—TPI1—osteoporosis	1.2e-06	0.0012	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—WNT1—osteoporosis	1.2e-06	0.0012	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PNP—osteoporosis	1.2e-06	0.0012	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—ATIC—osteoporosis	1.2e-06	0.0012	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—FGA—osteoporosis	1.17e-06	0.00116	CbGpPWpGaD
Tiotropium—CHRM1—GPCR ligand binding—POMC—osteoporosis	1.16e-06	0.00116	CbGpPWpGaD
Tiotropium—CHRM3—GPCR ligand binding—POMC—osteoporosis	1.16e-06	0.00115	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—ADCY5—osteoporosis	1.15e-06	0.00115	CbGpPWpGaD
Tiotropium—CHRM2—GPCR ligand binding—POMC—osteoporosis	1.15e-06	0.00114	CbGpPWpGaD
Tiotropium—CHRM2—SIDS Susceptibility Pathways—IL6—osteoporosis	1.14e-06	0.00114	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—CALCA—osteoporosis	1.14e-06	0.00114	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—CALCA—osteoporosis	1.13e-06	0.00113	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—P4HB—osteoporosis	1.13e-06	0.00113	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—CALCA—osteoporosis	1.12e-06	0.00112	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—GAPDH—osteoporosis	1.11e-06	0.00111	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—TLN1—osteoporosis	1.1e-06	0.0011	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—TLN1—osteoporosis	1.1e-06	0.00109	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—BMP2—osteoporosis	1.08e-06	0.00108	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—PTHLH—osteoporosis	1.08e-06	0.00108	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—TLN1—osteoporosis	1.08e-06	0.00108	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—RAP1A—osteoporosis	1.08e-06	0.00108	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—FGB—osteoporosis	1.06e-06	0.00106	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—PSMA5—osteoporosis	1.02e-06	0.00102	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—PSMA2—osteoporosis	1.02e-06	0.00102	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—OXCT1—osteoporosis	1.02e-06	0.00102	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CA2—osteoporosis	1.02e-06	0.00102	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—MGLL—osteoporosis	9.94e-07	0.000991	CbGpPWpGaD
Tiotropium—CYP3A4—Biological oxidations—POMC—osteoporosis	9.59e-07	0.000956	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CALCA—osteoporosis	9.55e-07	0.000952	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—P4HB—osteoporosis	9.47e-07	0.000945	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—P4HB—osteoporosis	9.44e-07	0.000942	CbGpPWpGaD
Tiotropium—CHRM1—Circadian rythm related genes—IL6—osteoporosis	9.44e-07	0.000941	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—P4HB—osteoporosis	9.35e-07	0.000933	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—POMC—osteoporosis	9.31e-07	0.000929	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PTH—osteoporosis	9.22e-07	0.000919	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PTH—osteoporosis	9.19e-07	0.000916	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PTH—osteoporosis	9.1e-07	0.000907	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—RAP1A—osteoporosis	9.06e-07	0.000903	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PKM—osteoporosis	9.04e-07	0.000902	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—FDPS—osteoporosis	9.04e-07	0.000902	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—RAP1A—osteoporosis	9.03e-07	0.000901	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CNR2—osteoporosis	8.98e-07	0.000896	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CNR2—osteoporosis	8.95e-07	0.000893	CbGpPWpGaD
Tiotropium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	8.94e-07	0.000892	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—RAP1A—osteoporosis	8.94e-07	0.000892	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—ADCY5—osteoporosis	8.92e-07	0.000889	CbGpPWpGaD
Tiotropium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	8.91e-07	0.000889	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—ADCY5—osteoporosis	8.89e-07	0.000886	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CNR2—osteoporosis	8.87e-07	0.000884	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—NFATC1—osteoporosis	8.84e-07	0.000881	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—NFATC1—osteoporosis	8.81e-07	0.000879	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—ADCY5—osteoporosis	8.8e-07	0.000878	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—DKK1—osteoporosis	8.77e-07	0.000874	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—DKK1—osteoporosis	8.74e-07	0.000872	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—ENO1—osteoporosis	8.73e-07	0.000871	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—NFATC1—osteoporosis	8.72e-07	0.00087	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—KL—osteoporosis	8.67e-07	0.000865	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—DKK1—osteoporosis	8.65e-07	0.000863	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PSMA2—osteoporosis	8.6e-07	0.000858	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PSMA5—osteoporosis	8.6e-07	0.000858	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GPD2—osteoporosis	8.57e-07	0.000855	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PGLS—osteoporosis	8.57e-07	0.000855	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—POMC—osteoporosis	8.46e-07	0.000844	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—IDH2—osteoporosis	8.45e-07	0.000843	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—WNT1—osteoporosis	8.44e-07	0.000842	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—WNT1—osteoporosis	8.42e-07	0.00084	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—WNT1—osteoporosis	8.34e-07	0.000831	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—IL6R—osteoporosis	8.25e-07	0.000823	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—FGA—osteoporosis	8.21e-07	0.000819	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—FGA—osteoporosis	8.19e-07	0.000817	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—FGA—osteoporosis	8.11e-07	0.000809	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—ADCY5—osteoporosis	8.1e-07	0.000807	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—ADCY5—osteoporosis	8.07e-07	0.000805	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—ADCY5—osteoporosis	7.99e-07	0.000797	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CYP27A1—osteoporosis	7.94e-07	0.000792	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ATIC—osteoporosis	7.84e-07	0.000782	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PNP—osteoporosis	7.84e-07	0.000782	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—ACP5—osteoporosis	7.73e-07	0.000771	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—BMP2—osteoporosis	7.64e-07	0.000762	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PTHLH—osteoporosis	7.64e-07	0.000762	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PTHLH—osteoporosis	7.61e-07	0.000759	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—BMP2—osteoporosis	7.61e-07	0.000759	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PTHLH—osteoporosis	7.54e-07	0.000752	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—BMP2—osteoporosis	7.54e-07	0.000752	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—FGB—osteoporosis	7.47e-07	0.000745	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—FGB—osteoporosis	7.45e-07	0.000743	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—FGB—osteoporosis	7.38e-07	0.000736	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PSMA2—osteoporosis	7.21e-07	0.00072	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PSMA5—osteoporosis	7.21e-07	0.00072	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PSMA2—osteoporosis	7.19e-07	0.000717	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PSMA5—osteoporosis	7.19e-07	0.000717	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—TPI1—osteoporosis	7.18e-07	0.000716	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PSMA2—osteoporosis	7.12e-07	0.00071	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PSMA5—osteoporosis	7.12e-07	0.00071	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—CYP19A1—osteoporosis	6.98e-07	0.000696	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—ADCY5—osteoporosis	6.79e-07	0.000677	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—P4HB—osteoporosis	6.75e-07	0.000674	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CALCA—osteoporosis	6.72e-07	0.000671	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CALCA—osteoporosis	6.7e-07	0.000668	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CA2—osteoporosis	6.67e-07	0.000665	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—OXCT1—osteoporosis	6.67e-07	0.000665	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CALCA—osteoporosis	6.64e-07	0.000662	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GAPDH—osteoporosis	6.63e-07	0.000661	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—SPP1—osteoporosis	6.57e-07	0.000655	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—POMC—osteoporosis	6.56e-07	0.000654	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—POMC—osteoporosis	6.54e-07	0.000652	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—MGLL—osteoporosis	6.5e-07	0.000648	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—POMC—osteoporosis	6.47e-07	0.000646	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—RAP1A—osteoporosis	6.46e-07	0.000644	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—KL—osteoporosis	6.11e-07	0.000609	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—KL—osteoporosis	6.09e-07	0.000607	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—KL—osteoporosis	6.03e-07	0.000601	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—POMC—osteoporosis	5.95e-07	0.000594	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—IRS2—osteoporosis	5.94e-07	0.000593	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—POMC—osteoporosis	5.94e-07	0.000592	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—POMC—osteoporosis	5.88e-07	0.000586	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—LEP—osteoporosis	5.82e-07	0.00058	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—IL6R—osteoporosis	5.81e-07	0.000579	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—IL6R—osteoporosis	5.79e-07	0.000578	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—IL6R—osteoporosis	5.73e-07	0.000572	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—ADCY5—osteoporosis	5.7e-07	0.000569	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—GPX1—osteoporosis	5.68e-07	0.000567	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—ESR1—osteoporosis	5.55e-07	0.000554	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—IDH2—osteoporosis	5.52e-07	0.000551	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—MTHFR—osteoporosis	5.24e-07	0.000523	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—ENO1—osteoporosis	5.22e-07	0.000521	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CYP27A1—osteoporosis	5.19e-07	0.000518	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—IRS1—osteoporosis	5.19e-07	0.000517	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PSMA5—osteoporosis	5.14e-07	0.000513	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PSMA2—osteoporosis	5.14e-07	0.000513	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ACP5—osteoporosis	5.05e-07	0.000504	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—POMC—osteoporosis	5e-07	0.000498	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—IL6R—osteoporosis	4.87e-07	0.000486	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—IGF1—osteoporosis	4.81e-07	0.000479	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—ADCY5—osteoporosis	4.78e-07	0.000477	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—ADCY5—osteoporosis	4.77e-07	0.000475	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—ADCY5—osteoporosis	4.72e-07	0.000471	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—TPI1—osteoporosis	4.7e-07	0.000468	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—SPP1—osteoporosis	4.63e-07	0.000461	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—SPP1—osteoporosis	4.61e-07	0.00046	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—SPP1—osteoporosis	4.57e-07	0.000456	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—P4HB—osteoporosis	4.42e-07	0.00044	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GAPDH—osteoporosis	4.33e-07	0.000432	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—RAP1A—osteoporosis	4.22e-07	0.000421	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—POMC—osteoporosis	4.19e-07	0.000418	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—IRS2—osteoporosis	4.18e-07	0.000417	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CYP19A1—osteoporosis	4.17e-07	0.000416	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—IRS2—osteoporosis	4.17e-07	0.000416	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—IRS2—osteoporosis	4.13e-07	0.000412	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—LEP—osteoporosis	4.09e-07	0.000408	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—LEP—osteoporosis	4.08e-07	0.000407	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—LEP—osteoporosis	4.04e-07	0.000403	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—ESR1—osteoporosis	3.91e-07	0.00039	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—ESR1—osteoporosis	3.9e-07	0.000389	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—ESR1—osteoporosis	3.86e-07	0.000385	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—IL6—osteoporosis	3.68e-07	0.000367	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—IRS1—osteoporosis	3.65e-07	0.000364	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—IRS1—osteoporosis	3.64e-07	0.000363	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—IRS1—osteoporosis	3.61e-07	0.00036	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—POMC—osteoporosis	3.52e-07	0.000351	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—POMC—osteoporosis	3.51e-07	0.00035	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—POMC—osteoporosis	3.47e-07	0.000346	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—IL6R—osteoporosis	3.43e-07	0.000342	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—IL6R—osteoporosis	3.42e-07	0.000341	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ENO1—osteoporosis	3.41e-07	0.00034	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—ADCY5—osteoporosis	3.41e-07	0.00034	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GPX1—osteoporosis	3.4e-07	0.000339	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—IL6R—osteoporosis	3.39e-07	0.000338	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—IGF1—osteoporosis	3.38e-07	0.000337	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—IGF1—osteoporosis	3.37e-07	0.000336	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PSMA2—osteoporosis	3.36e-07	0.000335	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PSMA5—osteoporosis	3.36e-07	0.000335	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—IGF1—osteoporosis	3.34e-07	0.000333	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—MTHFR—osteoporosis	3.14e-07	0.000313	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—MYC—osteoporosis	2.89e-07	0.000288	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—TGFB1—osteoporosis	2.88e-07	0.000287	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CYP19A1—osteoporosis	2.73e-07	0.000272	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—IL6—osteoporosis	2.59e-07	0.000258	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—IL6—osteoporosis	2.58e-07	0.000257	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—IL6—osteoporosis	2.55e-07	0.000255	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—POMC—osteoporosis	2.51e-07	0.00025	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ADCY5—osteoporosis	2.23e-07	0.000222	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GPX1—osteoporosis	2.22e-07	0.000222	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—IL6—osteoporosis	2.17e-07	0.000217	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—MTHFR—osteoporosis	2.05e-07	0.000204	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—MYC—osteoporosis	2.03e-07	0.000203	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—TGFB1—osteoporosis	2.03e-07	0.000202	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—MYC—osteoporosis	2.03e-07	0.000202	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—TGFB1—osteoporosis	2.02e-07	0.000202	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—MYC—osteoporosis	2.01e-07	0.0002	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—TGFB1—osteoporosis	2e-07	0.0002	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—POMC—osteoporosis	1.64e-07	0.000164	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—IL6—osteoporosis	1.53e-07	0.000152	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—IL6—osteoporosis	1.52e-07	0.000152	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—IL6—osteoporosis	1.51e-07	0.000151	CbGpPWpGaD
